Gene · 9436
Papers3,322
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,322
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| dl-THP recovered the decreased NKp44 expression level on CD56dim CD16+ natural killer cells partially in choriocarcinoma microenvironment. | Immunobiology | 2023 | 36870142 | PubTator, text mining | PubMed |
| The central role of natural killer cells in preeclampsia. | Front Immunol | 2023 | 36865565 | PubTator, text mining | PubMed |
| Potential value of efficacy prediction and treatment of natural killer cells in extensive stage small cell lung cancer. | Thorac Cancer | 2023 | 36861174 | PubTator, text mining | PubMed |
| Alterations in the immune system persist after one year of convalescence in severe COVID-19 patients. | Front Immunol | 2023 | 36860856 | PubTator, text mining | PubMed |
| Photoluminescent Properties and Mechanism of Novel Cyanine-Borondifluoride Curcuminoid Hybrids as Red-to-Near Infrared and Endoplasmic Reticulum-Targeting Dyes. | Chemistry | 2023 | 36855249 | PubTator, text mining | PubMed |
| In Vitro Expansion of Vδ1+ T Cells from Cord Blood by Using Artificial Antigen-Presenting Cells and Anti-CD3 Antibody. | Vaccines (Basel) | 2023 | 36851283 | PubTator, text mining | PubMed |
| Synergistic therapeutic combination with a CAF inhibitor enhances CAR-NK-mediated cytotoxicity via reduction of CAF-released IL-6. | J Immunother Cancer | 2023 | 36849201 | PubTator, text mining | PubMed |
| Recurrent Abortion and the Involvement of Killer-Cell Immunoglobulin-like Receptor (KIR) Genes, Activated T Cells, NK Abnormalities, and Cytokine Profiles. | J Clin Med | 2023 | 36835892 | PubTator, text mining | PubMed |
| Natural Killer Cell-Derived Extracellular Vesicles as a Promising Immunotherapeutic Strategy for Cancer: A Systematic Review. | Int J Mol Sci | 2023 | 36835438 | PubTator, text mining | PubMed |
| Efficient Redirection of NK Cells by Genetic Modification with Chemokine Receptors CCR4 and CCR2B. | Int J Mol Sci | 2023 | 36834542 | PubTator, text mining | PubMed |
| NKG2A Immune Checkpoint in Vδ2 T Cells: Emerging Application in Cancer Immunotherapy. | Cancers (Basel) | 2023 | 36831606 | PubTator, text mining | PubMed |
| A Killer Disarmed: Natural Killer Cell Impairment in Myelodysplastic Syndrome. | Cells | 2023 | 36831300 | PubTator, text mining | PubMed |
| The Role of COX-2 and PGE2 in the Regulation of Immunomodulation and Other Functions of Mesenchymal Stromal Cells. | Biomedicines | 2023 | 36830980 | PubTator, text mining | PubMed |
| Natural Killer T and Natural Killer Cell-Based Immunotherapy Strategies Targeting Cancer. | Biomolecules | 2023 | 36830717 | PubTator, text mining | PubMed |
| Immune mechanisms of group B coxsackievirus induced viral myocarditis. | Virulence | 2023 | 36827455 | PubTator, text mining | PubMed |
| KIR/KIR-ligand genotypes and clinical outcomes following chemoimmunotherapy in patients with relapsed or refractory neuroblastoma: a report from the Children's Oncology Group. | J Immunother Cancer | 2023 | 36822669 | PubTator, text mining | PubMed |
| Mapping the interplay between NK cells and HIV: therapeutic implications. | J Leukoc Biol | 2023 | 36822173 | PubTator, text mining | PubMed |
| Pathogenesis and treatment of Sjogren's syndrome: Review and update. | Front Immunol | 2023 | 36817420 | PubTator, text mining | PubMed |
| Metagenomic and single-cell RNA-Seq survey of the Helicobacter pylori-infected stomach in asymptomatic individuals. | JCI Insight | 2023 | 36810249 | PubTator, text mining | PubMed |
| Cross-talk between cancer stem cells and immune cells: potential therapeutic targets in the tumor immune microenvironment. | Mol Cancer | 2023 | 36810098 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9436/papers?page=19